InDex Pharmaceuticals presents mechanism of action data for cobitolimod at the ECCO congress
ECCO 2022
Inflammatory Bowel Diseases
European Crohn´s and Colitis Organisation - ECCO - Why become a Corporate Member
EFCCA Symposium: Digital Health and Data Collection | efcca.org
PDF) Corrigendum: Exposure—efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease
European Crohn´s and Colitis Organisation - ECCO - Past Congresses
European Crohn´s and Colitis Organisation - ECCO - Volume 13, Issue 3
ECCO IBD by OCEAiN Organisation, Congress, Emotion, Association, iNnovation GmbH
ECCO guidelines & sites - GETAID
Conferences – E.C.C.O.
Patient Centricity in IBD Treatment: An Interview with Dr Corey Siegel at the 13th Congress of ECCO - European Medical Journal
ECCO Congress | efcca.org
ECCO - European Crohn's and Colitis Organisation | eMedEvents
Inflammatory Bowel Diseases
European Crohn´s and Colitis Organisation - ECCO - ECCO News
European Crohn´s and Colitis Organisation - ECCO - ECCO News
ECCO 2018
13th Congress of ECCO
ECCO 2018
PDF) 4th Congress of ECCO Inflammatory Bowel Diseases Impact of antiTNF treatment on Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: real world data in Germany
European Crohn´s and Colitis Organisation - ECCO - Paediatric news from the 13th Congress of ECCO 2018
ECCO 2018
ECCO: Improving outcomes for all cancer patients in Europe through multidisciplinarity - Research Outreach
Immunology
